Pragmatic trials in primary health care: What, when and how?

Family Practice

Volumn 27, Issue 6, 2010, Pages 591-592

  Eldridge, Sandra ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL; EDITORIAL; HUMAN; MEDICAL RESEARCH; METHODOLOGY; OUTCOME ASSESSMENT; PRAGMATIC TRIAL; PRIMARY HEALTH CARE; QUALITY CONTROL; SYSTEMATIC ERROR; THERAPY EFFECT;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; PRIMARY HEALTH CARE;

EID: 78649370537     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmq099     Document Type: Editorial

References (11)

1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967; 20: 637-48.
2. Roland M, Torgerson DJ. What are pragmatic trials? BMJ 1998; 316: 285.
3. Zwarenstein M, Treweek S, Gagnier JJ et al. CONSORT group; Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008; 337: a2390.
4. Thorpe KE, Zwarenstein M, Oxman AD et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ 2009; 180: E47-57.
5. Zwarenstein M, Treweek S. What kind of randomised trials do patients and clinicians need? Evid Based Med 2009; 14: 101-3.
6. Fletcher K, Mant J, Roalfe A, Hobbs FDR. Impact of study design on recruitment of patients to primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) Study. Fam Pract 2010; 27: 691-697.
7. White HJ, Bettiol SS, Perera R, Roberts NW et al. A systematic review assessing the effectiveness of interventions to improve persistence with anti-resorptive therapy in women at high risk of clinical fracture. Fam Pract 2010; 27: 593-603.
8. Riley BL, MacDonald J, Mansi O et al. Is reporting on interventions a weak link in understanding how and why they work? A preliminary exploration using community heart health exemplars. Implement Sci 2008; 3: 27.
9. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
10. Delmas PD, Vrijens B, Eastell R et al. Improving Measurements of Persistence on Actonel Treatment (IMPACT) Investigators. Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 2007; 92: 1296-304.
11. Eldridge S, Ashby D, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ 2008; 336: 876-80.